Biohealth Innovation - 304th Edition

BioHealth Innovation

If you are having trouble viewing this email, please click here

May 15, 2018

Live from the BioHealth Capital Region Forum – Part 1: Jim Jackson, SVP, CSO at Emergent BioSolutions and Jim Hughes, Vice President at University of Maryland, Baltimore

In this first part of two episodes, Rich sits down with leaders from different parts of the BHCR to talk about what they are working on, and their thoughts on the event. His guests are Jim Jackson, SVP, CSO at Emergent BioSolutions and Jim Hughes, Vice President at University of Maryland, Baltimore.

Listen now on iTunes , Google Play , and TuneIn.

Live from the BioHealth Capital Region Forum – Part 2: Todd Haim, SBIR Director, NCI SBIR Development Center at NIH, and Matthew McMahon, Director, Office of Translational Alliances and Coordination at the National Heart, Lung, and Blood Institute at NIH

In this second part of two episodes, Rich sits down with leaders from different parts of the BHCR to talk about what they are working on, and their thoughts on the event. His guests are Todd Haim, SBIR Director, NCI SBIR Development Center at NIH, and Matthew McMahon, Director, Office of Translational Alliances and Coordination at the National Heart, Lung, and Blood Institute at NIH

Listen now on iTunes , Google Play , and TuneIn.

4 States Control 80 Percent of Venture Capital Dollars - MARYLAND climbs to number 6

More than half of all venture capital dollars invested in small businesses and startups during the first three months of 2018 went straight into the state of California, according to a recent investment report from PwC and CB Insights suggesting the vast majority of business investment in the U.S. is concentrated in only a few states.

BeneVir Biopharm Inc. to be acquired by Janssen Biotech Inc. for up to $1.04B - Washington Business Journal

Rockville-based BeneVir Biopharm Inc., a biotech specializing in immunotherapy treatments for cancer, has reached a deal to sell to pharmaceutical goliath Janssen Biotech Inc., a Johnson & Johnson company, in a deal worth up to $1.04 billion.

Emergent BioSolutions Moves Things Around -- The Motley Fool

The first-quarter numbers for Emergent BioSolutions (NYSE:EBS) didn't look too great. In fact, they were arguably ugly.

Traumatic Brain Injury Research by Emmes Corporation, LDS Hospital, Lovelace Biomedical

The Emmes Corporation today announced that scientists and health professionals from the company, LDS Hospital in Salt Lake City, Utah, Lovelace Biomedical Environmental Research Institute in Albuquerque, New Mexico, and the U.S. Army Medical and Materiel Development Activity at Fort Detrick, Maryland, have completed a multi-year clinical trial testing hyperbaric oxygen as an intervention for U.S. military service members who have suffered mild traumatic brain injuries with persistent symptoms.

Johns Hopkins effort to promote economic growth in Baltimore exceeds expectations - Hub

It pays to be a business in Baltimore. That's the message that Johns Hopkins wants proprietors and their patrons to know as part of the institution's HopkinsLocal initiative to support and invest in local enterprises.

Medical device inventor Robert E. Fischell gives University of Maryland School of Medicine $20 million to establish center for biomedical innovation - Baltimore Business Journal

Famous local inventor Robert E. Fischell is gifting $20 million to the University of Maryland School of Medicine in support of biomedical research.

The gift will be used to establish the Robert E. Fischell Center for Biomedical Innovation at the medical school, and provide funding for a planned new 450,000 square foot research building on the school's Baltimore campus. It will also support research funds and endowed professorships for the new Fischell Center.

Intralytix Acquires Site for New Headquarters

Intralytix, Inc., announced today that it has closed on the acquisition of a 33,000 sq. ft. building in Columbia, Maryland. The facility, located in the Columbia Gateway Community, will serve as the Company's new headquarters. Plans are underway to house expanded research and laboratory space, executive offices, and substantially increased manufacturing capacity.

UMD announces $1.5 billion fundraising campaign that’s halfway complete - The Diamondback

The University of Maryland announced its goal Friday to fundraise $1.5 billion by the end of 2021 for numerous construction projects, scholarship funds and program upgrades, according to a news release.

Seoul to spend massive money in biohealth sector - Korea Biomedical Review

The government said Friday it would spend 7.5 trillion won ($7 billion) to support the biohealth sector by 2022 aggressively.

The Ministry of Trade, Industry and Energy launched “Industrial Innovation 2020 Platform” with private companies and experts to discuss cooperative measures to accelerate private sector-driven industrial innovation and growth.

Japan's Takeda clinches $62 billion Shire deal as pharma M&A rolls on - Reuters

Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($62 billion) on Tuesday, the biggest yet in a wave of deals sweeping the drugs industry.

The Collective Seattle Is A Clubhouse For Big Kids - Commercial Real Estate

Think of The Collective as a 15K SF clubhouse for big kids. Grownups are welcome, but leave your electronic devices in your pockets, please. This is about face-to-face fun.

Army Doctors Grew a Soldier a New Ear — On Her Forearm - Time

You’ve heard the cliché about wearing your heart on your sleeve. But a group of Army doctors did one better: They grew a new ear on a soldier’s forearm, using cartilage harvested from her ribs.